Blockers of Wnt3a, Wnt10a, or β-Catenin Prevent Chemotherapy-Induced Neuropathic Pain In Vivo

Hee Kee Kim(Texas Southern University), Salahadin Abdi(The University of Texas MD Anderson Cancer Center)

Neurotherapeutics

October 30, 2020

10.1007/s13311-020-00956-w

Cited by 25

Related Papers

An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations.

|PubMed|2013|311

Tempol Ameliorates and Prevents Mechanical Hyperalgesia in a Rat Model of Chemotherapy-Induced Neuropathic Pain

|Frontiers in Pharmacology|2017|47

Bardoxolone Methyl Ameliorates Chemotherapy-Induced Neuropathic Pain by Activation of Phosphorylated Nuclear Factor Erythroid 2-Related Factor 2 in the Dorsal Root Ganglia

|Anesthesia & Analgesia|2023|3

Exacerbation of paclitaxel-induced neuropathic pain behaviors in breast tumor–bearing mice

|Molecular Pain|2025|0